One-step decellularization of porcine uterine tissue for developing alginate-decellularized uterine ECM hydrogel for uterine tissue engineering
Abbas Fazel Anvari-Yazdi , Kobra Tahermanesh , Maryam Ejlali , Louison Blivet-Bailly , Vatsala Singh , Bishnu Acharya , Daniel J. MacPhee , Ildiko Badea , Xiongbiao Chen
International Journal of Bioprinting ›› 2026, Vol. 12 ›› Issue (3) : 026150132
Decellularized uterine extracellular matrix (dUECM) is promising for uterine tissue engineering because of its inherent bioactivity and structural complexity. However, transforming dUECM into porous, functional 3D constructs remains a significant challenging. This study aimed to: (1) synthesize dUECM using a modified decellularization protocol and formulate it into a hydrogel ink, and (2) to fabricate 3D-printed constructs from this ink to assess their capacity to support human uterine myometrial cell growth in vitro. Porcine uterine tissues were decellularized using 1% Triton™ X-100 with varying concentrations of sodium dodecyl sulfate (SDS) (0.1–1.5%) for 48–72 h. The resulting dUECM was characterized using DNA and glycosaminoglycan (GAG) quantification, Picrosirius Red-polarized light microscopy, routine histology, scanning electron microscopy (SEM), Fourier-transform infrared spectroscopy (FTIR), Raman spectroscopy, and thermogravimetric analysis (TGA). To prepare the ink, dUECM powder was enzymatically digested with pepsin and subsequently blended with 2% and 3% alginate to obtain a printable hydrogel formulation. Constructs were fabricated using extrusion-based 3D printing and assessed for filament fidelity, swelling, degradation behavior, and mechanical properties. Biocompatibility was evaluated using hTERT-HM myometrial cells through MTT metabolic assays, Live/Dead staining, and immunohistochemical α-SMA staining. The optimal protocol (1% Triton™ X-100 + 1% SDS for 48 h) reduced DNA to 51.3 ± 9 ng/mg while retaining a high level of GAGs (54.9 ± 7.6 μg/mg). Preservation of the ECM structure was confirmed by spectroscopy analyses. The 3% Alg + 1.5% dUECM hydrogel exhibited suitable printability (1.5 ± 0.2), swelling capacity (47 ± 12%), degradation resistance (94 ± 18% mass retention), and mechanical strength (decreasing from 323 kPa to 175 kPa over 14 days), along with high viability and proliferation (258 ± 13%). The developed dUECM-based hydrogel supports 3D bioprinting with strong mechanical and biological performance, offering a promising platform for uterine tissue engineering.
Tissue engineering / Hybrid hydrogel / Scaffolds / 3D-extrusion printing / Uterine smooth muscle / Extracellular matrix
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
/
| 〈 |
|
〉 |